Clinical Trial Update: Propionic Acid in Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial of propionic acid for multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Propionic acid (Propionic acid)

Snippet

Sponsor: Salzburger Landeskliniken | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED